Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of...
1 insider purchase on record · latest filing 2026-09-28.
Insiders have also filed 1 sale transaction at DMRA.